Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
BACKGROUND: Low-dose aspirin is of definite and substantial net benefit for many people who already have occlusive vascular disease. We have assessed the benefits and risks in primary prevention. METHODS: We undertook meta-analyses of serious vascular events (myocardial infarction, stroke, or vascul...
Main Authors: | Baigent, C, Blackwell, L, Collins, R, Emberson, J, Godwin, J, Peto, R, Buring, J, Hennekens, C, Kearney, P, Meade, T, Patrono, C, Roncaglioni, M, Zanchetti, A |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
Elsevier
2009
|
Títulos similares
-
Efficacy of aspirin in people with diabetes: an individual participant data meta-analysis of 26 randomised trials
por: Wong, C, et al.
Publicado: (2014) -
Aspirin in the primary prevention of vascular disease Reply
por: Baigent, C, et al.
Publicado: (2009) -
Aspirin in the primary prevention of vascular disease Reply
por: Baigent, C, et al.
Publicado: (2009) -
Aspirin and stroke.
por: Buring, J, et al.
Publicado: (1990) -
Aspirin in ischemic heart disease.
por: Hennekens, C, et al.
Publicado: (1992)